Chronic Myelogenous Leukemia in Adults

We conduct sophisticated diagnostic tests such as chromosomal analysis to identify chronic myelogenous leukemia, a slow-growing cancer of the bone marrow and blood. We offer targeted chemotherapy that helps some people achieve long-term remission, in which cancer cells are no longer detected in the body. Stem cell transplantation is available for more aggressive cancer. We also provide psychosocial support to help you thrive during treatment for this chronic condition.

Clinical Trials and Research Studies

Phase 1

A PHASE 1 STUDY OF MILADEMETAN IN COMBINATION WITH QUIZARTINIB IN SUBJECTS WITH FLT3-ITD MUTANT ACUTE MYELOID LEUKEMIA THAT ARE RELAPSED/REFRACTORY OR NEWLY DIAGNOSED AND UNFIT FOR INTENSIVE CHEMOTHERAPY

Learn More

Phase 2

AAML18P1: Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia - Chronic Phase (CML-CP)

Learn More

Phase 3

AALL1631: International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Ph+ ALL Testing Imatinib in Combination with Two Different Cytotoxic Chemotherapy Backbones

Learn More

Phase 3

AALL1731: A Phase 3 Trial Investigating Blinatumomab (IND# 117467 NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)

Learn More